title: Orexin A Affects INS-1 Rat Insulinoma Cell Proliferation via Orexin Receptor 1 and the AKT Signaling Pathway.
abstract: Our aim is to investigate the role of the AKT/PKB (protein kinase B) signaling pathway acting via orexin receptor 1 (OX1R) and the effects of orexin A (OXA) on cell proliferation in the insulin-secreting beta-cell line (INS-1 cells). Rat INS-1 cells were exposed to different concentrations of OXA in vitro and treated with OX1R antagonist (SB334867), PI3K antagonist (wortmannin), AKT antagonist (PF-04691502), or negative control. INS-1 amount of cell proliferation, viability and apoptosis, insulin secretion, OX1R protein expression, caspase-3 activity, and AKT protein levels were determined. We report that OXA (10(-10) to 10(-6) M) stimulates INS-1 cell proliferation and viability, reduces the proapoptotic activity of caspase-3 to protect against apoptotic cell death, and increases insulin secretion. Additionally, AKT phosphorylation was stimulated by OXA (10(-10) to 10(-6) M). However, the OX1R antagonist SB334867 (10(-6) M), the PI3K antagonist wortmannin (10(-8) M), the AKT antagonist PF-04691502 (10(-6) M), or the combination of both abolished the effects of OXA to a certain extent. These results suggest that the upregulation of OXA-OX1R mediated by AKT activation may inhibit cell apoptosis and promote cell proliferation in INS-1 cells. This finding provides functional evidence of the biological actions of OXA in rat insulinoma cells.
authors.affiliation: Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
authors.forename: Li
authors.initials: L
authors.lastname: Chen
authors.affiliation: Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
authors.forename: Yuyan
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
authors.forename: Delu
authors.initials: D
authors.lastname: Zheng
authors.affiliation: Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
authors.forename: Shujing
authors.initials: S
authors.lastname: Ju
authors.affiliation: Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
authors.forename: Yang
authors.initials: Y
authors.lastname: Shen
authors.affiliation: Department of Orthopedic Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Guo